Ayre, Anita Pandurang;Marathe, Deepak Subhash;Borkar, Shilpa published 《Formulation and evaluation of orodispersible films of bromhexine HCl-a patient friendly approach》 in 2016. The article was appeared in 《International Journal for Pharmaceutical Research Scholars》. They have made some progress in their research.Reference of 2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride The article mentions the following:
The present investigation was carried out with the objective of formulating orodispersible forms of the mucolytic drug, Bromhexine HCl to enhance convenience and compliance to the elderly and pediatric patients for better therapeutic efficacy. Orodispersible films of Bromhexine HCl were prepared by solvent evaporation technique. Formulation studies were carried out using different polymer combinations, the obtained films were evaluated for their appearance, color, elegance, continuity, texture, presence of air bubbles, stickiness to Petri dish, cracks, cuttings, and imperfections. Alginate and HPMC based films recorded the fastest disintegration when used alone and in mixtures with PVP-K25 and maltodextrin. Xanthan gum film had the longest disintegration time. Moreover, adding xanthan gum, Na CMC, and carbopol prolonged the disintegration time of HPMC and alginate films. A good correlation existed between the calculated dissolution rate of each film and its disintegration time. Formulas F1and F7 showed the highest resistance against moisture absorption and recoded tensile strength values of 15.47 and 17.16 kg/mm2, resp. after storage. Films based on HPMC alone or in combination with other polymers exhibited high resistance against moisture absorption except with Na CMC. Alginate and xanthan gum based films had a higher affinity for moisture absorption. The addition of maltodextrin significantly decreased the percentage moisture absorption after storage at 97% relative humidity. This effect was concentration-dependent. Thus disintegration time of film was 25 s, drug content 92.4 % and drug release was 96.3 %. The developed formulation was found to be stable under the conditions tested. To complete the study, the researchers used 2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride (cas: 611-75-6) .
2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride(cas: 611-75-6) is intended to support the body’s mechanisms for clearing mucus from the respiratory tract. Bromhexine is a synthetic derivative of the herbal active ingredient vasicine. It has been shown to increase the proportion of serous bronchial secretion, making it more easily expectorated. It is indicated as secretolytic therapy in bronchopulmonary diseases associated with abnormal mucus secretion and impaired mucus transport.Reference of 2,4-Dibromo-6-((cyclohexyl(methyl)amino)methyl)aniline hydrochloride
Reference:
Bromide – Wikipedia,
bromide – Wiktionary